Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Parkinsonism: Onset, Progression, And Mortality

M. Hoehn, M. Yahr
Published 1967 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
PARKINSONISM, described in its entirety over one hundred and fifty years ago,’ rarely presents itself as a diagnostic problem. In consequence, little scrutiny has been directed to the marked variability of this frequently encountered neurological syndrome and to the progression of the disease in large groups of patients. As with most chronic neurological disorders, marked diversity can be expected to exist in age and mode of onset, relative prominence of the cardinal signs and symptoms, rate of progression, and resultant degree of functional impairment. Controversy over the effectiveness of therapeutic measures for parkinsonism is due partially to this wide variability and to the paucity of clinical information about the natural history of the syndrome. It is also re-
This paper references
In: The Shaking Palsy. A Symposium
Haymaker (1959)
10.1007/springerreference_34125
Paralysis agitans.
H. F. Maudsley (1953)
10.1093/QJMED/15.59.155
Changes in the Parkinsonian syndrome in the Twentieth Century.
H. Dimsdale (1946)
Summary of vital statistics
City Of New Yo
s.: Paralysis agitans: some clinical observations based on the study of 219 cases seen at the clinic
T. HART (1904)
De la paralysie agitante
J M Charcot
REGISTRAR GENERAL: Statistical review of England and Wales for the year 1951. Medical certification of causes of death. Multiple cause analysis
(1953)
10.1093/BRAIN/72.2.113
OBSERVATIONS ON ESSENTIAL (HEREDOFAMILIAL) TREMOR
M. Critchley (1949)
In: The Shaking Palsy. A Symposium
D Howell (1959)
De la paralysie agitante. Lesons sur les Maladies du Systeme Nerveux, Recueillies et Publibes par Bourneville
Charcot (1880)
10.1001/jama.1965.03080110060021
ENCEPHALITIS AND PARKINSONISM.
W. D. Bowman (1965)
10.1001/JAMA.1956.02970270063024
CANCER AS A CAUSE OF DEATH AMONG PATIENTS WITH OTHER CHRONIC DISEASES
K. Westlund (1956)
Paralysis agitans. Dtsch. Klinik
Erb (1901)
Neurology. Baltimore
Wilson (1955)
10.1001/ARCHNEUR.1963.00460090038003
PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA.
R. Duvoisin (1963)
Pathogenesis and Treatment of Parkin11 . SCHWAB , ~ . s . : Progression and prognosis in Parkinson ’ s disease
w. s. FDELDS (1960)
Pathogenesis and Treatment of Parkin - 11 . SCHWAB , ~ . s . : Progression and prognosis in Parkinson ’ s disease
R. S. SCHWAB
10.1001/ARCHINTE.1951.03810060035004
Benign essential (heredofamilial) tremor.
C. H. Davis (1951)
Annual report of births, deaths, and marriages in England and Wales
Registrar General
Parkinson et cancer
J. JOLY (1954)
Morbidity and mortality in parkinsonism
Williams (1966)
Essential Tremor: A Clinical and Genetic Population Study
A. Falek (1960)
Observations on essential ( heredo - familial ) tremor
M. CRITCHLEY (1887)
Essential tremor: a clinical and genetic population study.
T. Larsson (1960)
10.1212/WNL.9.9.626
Pathogenesis and Treatment of Parkinsonism
Lippincott Williams Wilkins (1959)
Observations on essential ( heredo - familial ) tremor
B. v. JAGER (1949)
Pathogenesis and Treatment of Parkin - 11 . SCHWAB , ~ . s . : Progression and prognosis in Parkinson ’ s disease
w. s. FDELDS (1960)
10.1097/00005053-196006000-00017
PROGRESSION AND PROGNOSIS IN PARKINSON'S DISEASE
R. S. Schwab (1960)
Studies in the epidemiology of Parkinson's disease predicting its disappearance as a major clinical entity by 1980.
D. Poskanzer (1961)
10.1136/jnnp.27.3.237
Arteriosclerosis in Parkinsonism
M. Eadie (1964)
10.1097/00000441-191105000-00022
DIE PARALYSIS AGITANS
K. Mendel (1911)
Morbidity and mortality in parkinsonism
G. R. WILLIAMS (1957)
Parkinson ’ s disease : statistics
DE JONG (1855)
10.1001/JAMA.1954.02950070008003
Problem situations in the treatment of paralysis agitans.
L. J. Doshay (1954)
Paralysis Agitans. Amsterdam: van Rossen
Manschot (1904)
FDELDS, w. s.: Pathogenesis and Treatment of
10.2105/AJPH.40.3.344-A
Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Vol. I
H. Dorn (1950)
Clipical Neurology. Philadelphia: F
Alpers
10.1097/00000441-188710000-00005
HEREDITARY TREMOR, A HITHERTO UNDESCRIBED FORM OF MOTOR NEUROSIS.1
C. L. Dana (1887)
Hereditary tremor.
B. Jager (1955)
10.1212/WNL.6.11.783
Shift to Older Age Distribution in Parkinsonism
R. S. Schwab (1956)
Parkinson's disease: statistics
Jong De (1966)
w.: Paralysis Agitans
G. MANSCHOT (1904)
10.1136/jnnp.25.2.122
OBSERVATIONS ON ESSENTIAL TREMOR
J. Marshall (1962)
10.1097/00005053-190403000-00004
PARALYSIS AGITANS: SOME CLINICAL OBSERVATIONS BASED ON THE STUDY OF 219 CASES SEEN AT THE CLINIC OF PROFESSOR M. ALLEN STARR
T. Hart (1904)
10.1001/ARCHNEURPSYC.1922.02190120032002
PARKINSON'S DISEASE: A CLINICAL STUDY OF ONE HUNDRED AND FORTY-SIX CASES
Hugh T. Patrick (1922)
10.1111/J.1600-0404.1966.TB05991.X
THE OCCURRENCE OF PEPTIC ULCERATION IN PATIENTS WITH PARKINSONISM
R. Strang (1966)
10.1097/00005053-192410000-00124
An Essay on the Shaking Palsy
P. James (1817)
In: The Shaking Palsy. A Symposium
A Heyman (1959)
WORLD HEALTH ORGANIZATION: Manual of the international statistical classification of diseases, injuries, and causes of death
Jong De (1957)



This paper is referenced by
10.2217/FNL.10.9
Therapy for dyskinesias in Parkinson's disease patients
Alessandro Stefani (2010)
10.1371/journal.pone.0047138
The Effect of Motivation on Movement: A Study of Bradykinesia in Parkinson’s Disease
Tamara Shiner (2012)
COMPORTAMENTO LOCOMOTOR, QUADRO CLÍNICO, INCIDÊNCIA DE QUEDAS E NÍVEL DE ATIVIDADE FÍSICA EM PACIENTES COM DOENÇA DE PARKINSON. UM ESTUDO LONGITUDINAL DE DOIS ANOS
Rodrigo Vitório (2015)
Keha koostis ja kukkumisrisk kerge ja mõõduka raskusastmega Parkinsoni tõvega naistel
Grete Põder (2015)
10.12968/BJNN.2015.11.2.92
Parkinson's is complex: considering earlier use of advanced, non-oral therapies
Jane Mills (2015)
10.17116/jnevro201911909244
[Subjective and objective subtypes of excessive daytime sleepiness in Parkinson's disease].
Olena Iakovleva (2019)
10.3390/s19143103
Turning Analysis during Standardized Test Using On-Shoe Wearable Sensors in Parkinson’s Disease
Nooshin Haji Ghassemi (2019)
Innervation dopaminergique et sérotoninergique du striatum dans les maladies de Parkinson et d'Huntington
Catherine Bédard (2010)
nveiling relevant non-motor Parkinson ’ s disease severity symptoms sing a machine learning approach
ubén Armañanzasa (2013)
Validación de la versión en español del cuestionario de congelamiento de la marcha (FOG-Q) en enfermedad de Parkinson
Amin Cervantes Arriaga (2011)
10.33915/etd.4550
Characterizing the relation between depressive symptoms and Parkinson's disease in a sample of Swedish twins
Rebecca K. Widoe (2009)
10.1097/01893697-201331020-00005
Coexisting Prostate Cancer and Parkinson Disease Leading to Admission to Hospice: Considerations for Physical Therapy Intervention
Karen Mueller (2013)
10.1111/j.1600-0404.1996.tb00186.x
Cerebrospinal fluid nitrate levels in patients with Parkinson's disease
J. Molina (1996)
10.1590/S1516-44462009000100010
Depression in Parkinson's disease: clinical-epidemiological correlates and comparison with a controlled group of non-parkinsonian geriatric patients.
Beatriz Azevedo Dos Anjos Godke Veiga (2009)
10.1002/ccr3.2771
Tango therapy for Parkinson's disease: Effects of rush elemental tango therapy
Young-Soon Koh (2020)
10.1002/hbm.21318
Motor imagery evokes increased somatosensory activity in parkinson's disease patients with tremor
R. Helmich (2012)
10.1016/j.gaitpost.2017.09.021
Walking behavior over multiple obstacles in people with Parkinson's disease.
Diego Orcioli-Silva (2017)
10.1590/S0004-282X2012000800008
Validity of the Brazilian version of the freezing of gait questionnaire.
Jussara A. O. Baggio (2012)
10.1136/jnnp.2008.166629
Patterns of motor and non-motor features in Parkinson’s disease
S. V. van Rooden (2009)
10.1111/bpa.12730
Levels of glial cell line‐derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson’s disease
Sophie Virachit (2019)
10.1212/WNL.42.4.887
Abnormalities in color vision and contrast sensitivity in Parkinson's disease
M. J. Price (1992)
10.1212/WNL.41.2_Part_1.202
Early development of levodopa‐induced dyskinesias and response fluctuations in young‐onset Parkinson's disease
V. Kostíc (1991)
Clinical Characteristics of Sleep Disorders in Parkinson's Disease
H. Kim (2008)
10.1212/01.WNL.0000086810.14643.FC
Disappearance of resting tremor after “stereotaxic” thalamic stroke
S. Probst-Cousin (2003)
Reflexiones sobre la Biosíntesis de la Morfina y el Parkinson Idiopático Reflections on the biosynthesis of morphine and idiopathic Parkinson's disease
J. Perea-Sasiaín (2007)
10.1590/0004-282X20160074
Postural instability and falls are more frequent in Parkinson's disease patients with worse trunk mobility.
N. Artigas (2016)
10.1007/s00702-013-1051-8
The spectrum of preclinical gait disorders in early Parkinson’s disease: subclinical gait abnormalities and compensatory mechanisms revealed with dual tasking
P. Panyakaew (2013)
10.1177/0269215509358933
Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme on quality of life in patients with Parkinson’s disease
E. Dereli (2010)
Randomized , double-blind , placebo-controlled trial of vitamin D supplementation in Parkinson disease 1 – 4
M. Suzuki (2013)
10.1007/s00415-011-6261-0
Case–control study of blink rate in Parkinson’s disease under different conditions
E. Fitzpatrick (2011)
Frequency of Dementia in Parkinson’s Disease
Noor Ahmed Khosa (2013)
THE EFFECTS OF ATTENTIONAL FOCUS INSTRUCTIONS ON LEARNING OF BALANCE TASK AMONGST PARKINSON DISEASE PATIENTS
N. Zangiabadi (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar